CCM
MRK icon

Copernicus Capital Management’s Merck MRK Stock Holding History

Copernicus Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-77,552
Closed -$6.23M – 20
2019
Q3 		$6.23M Sell
77,552
-70,216
-48% -$5.63M 5.8% 10
2019
Q2 		$11.8M Buy
+147,768
New +$11.3M 10.52% 2
2019
Q1 		– Sell
-71,747
Closed -$5.23M – 16
2018
Q4 		$5.23M Buy
+71,747
New +$5.06M 9.85% 5

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Copernicus Capital Management's MRK Position: Q4 2019 in Review

Copernicus Capital Management sold out of Merck (MRK) in Q4 2019, closing a stake of 77,552 shares — an estimated $6.23M sold.

Copernicus Capital Management first reported a position in MRK in Q4 2018 and held it in 3 quarters. The position peaked at $11.8M in Q2 2019. 2,536 funds tracked by Wall St. Rank hold MRK as of Q4 2019.

  • Copernicus Capital Management reported no remaining Merck position as of Q4 2019 after selling out during the quarter.
  • Copernicus Capital Management sold 77,552 Merck shares in Q4 2019, an estimated $6.23M.
  • Copernicus Capital Management first reported a position in Merck in Q4 2018 and held it in 3 quarters.
  • Copernicus Capital Management's Merck position peaked at $11.8M in Q2 2019.
  • 2,536 funds tracked by Wall St. Rank held Merck as of Q4 2019.

Based on Copernicus Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.